Annual Review of Cancer Biology

The Annual Review of Cancer Biology was first published in 2017, making it the 47th journal title published by Annual Reviews.[2] The stated goals of the journal were to cover the biology of tumor cells, the interaction between the tumor cells and host cells, cancer genomes, drugs for treating cancer, and the resistance of cancer to certain drugs.[3] Each volume has three broad themes: cancer cell biology, tumorigenesis and cancer progression, and translational cancer science.[4] Tyler Jacks and Charles L. Sawyers have been the editors since the first volume.[3] It is not published in print, and is only available electronically.[5] Under Annual Reviews's "Subscribe to Open" publishing model, the 2020 volume of Annual Review of Cancer Biology was published open access, a first for the journal.[6][7]

As of 2019, Journal Citation Reports lists the journal's impact factor as 5.413, ranking it 53rd of 244 journal titles in the category "Oncology".[1]

The Annual Review of Cancer Biology is helmed by the editors. The editors are assisted by the editorial committee, which includes associate editors, regular members, and occasionally guest editors. Guest members participate at the invitation of the editors, and serve terms of one year. All other members of the editorial committee are appointed by the Annual Reviews board of directors and serve five-year terms. The editorial committee determines which topics should be included in each volume and solicits reviews from qualified authors.[8] Unsolicited manuscripts are not accepted. Peer review of accepted manuscripts is undertaken by the editorial committee.[9]